Overview
Javier Guerra-Martin practices in Valladolid, Spain. Mr. Guerra-Martin is rated as a Distinguished expert by MediFind in the treatment of Hypersensitivity Vasculitis. His top areas of expertise are Hypersensitivity Vasculitis, Adie Syndrome, Tularemia, and Vasculitis.
His clinical research consists of co-authoring 56 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Hypersensitivity Vasculitis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Hypersensitivity VasculitisMr. Guerra-Martin isDistinguished. Learn about Hypersensitivity Vasculitis.
- Advanced
- Adie SyndromeMr. Guerra-Martin isAdvanced. Learn about Adie Syndrome.
- TularemiaMr. Guerra-Martin isAdvanced. Learn about Tularemia.
- Experienced
- ActinomycosisMr. Guerra-Martin isExperienced. Learn about Actinomycosis.
- Acute Interstitial PneumoniaMr. Guerra-Martin isExperienced. Learn about Acute Interstitial Pneumonia.
- Addison's DiseaseMr. Guerra-Martin isExperienced. Learn about Addison's Disease.
- Antisynthetase SyndromeMr. Guerra-Martin isExperienced. Learn about Antisynthetase Syndrome.
- Brain TumorMr. Guerra-Martin isExperienced. Learn about Brain Tumor.
- Chronic Obstructive Pulmonary Disease (COPD)Mr. Guerra-Martin isExperienced. Learn about Chronic Obstructive Pulmonary Disease (COPD).